Omniscan (Gadodiamide)

Gadodiamide, the active ingredient in Omniscan, is a contrast media presented as a solution for intravenous use in magnetic resonance imaging (MRI) procedures. It enhances image quality to aid diagnostic evaluation. GNH USA supplies Omniscan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Omniscan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Omniscan is a gadolinium‑based contrast agent used in magnetic resonance imaging to improve visualization of anatomical structures and pathological conditions.

- Central nervous system imaging: enhances detection of lesions, tumors, and vascular abnormalities. - Cardiovascular imaging: improves delineation of cardiac chambers, vessels, and myocardial perfusion. - Whole‑body and oncologic imaging: aids in identifying metastatic disease and evaluating treatment response.

Adverse reactions to gadodiamide‑based contrast agents are generally infrequent but can vary in severity.

Common Side Effects: - Nausea: mild and transient. - Headache: occasional during or after injection. - Injection site discomfort: mild pain or warmth at the site. - Warm sensation: brief feeling of heat throughout the body. - Metallic taste: transient metallic sensation in the mouth. - Dizziness: mild, short‑lived episodes.

Serious or Rare Side Effects: - Nephrogenic systemic fibrosis (NSF): fibrotic skin changes in patients with severe renal impairment. - Anaphylactoid reactions: hives, bronchospasm, or hypotension. - Severe hypersensitivity: angio‑edema or respiratory distress. - Cardiac arrest: rare but life‑threatening event. - Renal toxicity: acute kidney injury in susceptible individuals. - Death: extremely rare, reported in severe anaphylactic cases.

When administering Omniscan, clinicians should assess patient risk factors and follow recommended safety protocols.

- Renal function assessment: evaluate glomerular filtration rate before use. - History of allergic reactions: review prior contrast media reactions. - Pregnancy considerations: use only if essential, after risk‑benefit analysis. - Pediatric use: adjust dosing based on weight and clinical need. - Concomitant nephrotoxic drugs: avoid or monitor closely. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Gadodiamide may interact with other agents that affect renal function or hypersensitivity risk.

Major Interactions (Avoid): - Nephrotoxic antibiotics (e.g., aminoglycosides): increase risk of renal injury. - High‑dose intravenous iron: may alter gadolinium clearance.

Moderate Interactions (Monitor Closely): - Loop diuretics: may affect fluid balance and renal excretion. - ACE inhibitors/ARBs: monitor kidney function when combined. - Metformin: assess renal function to avoid lactic acidosis risk. - NSAIDs: increased potential for renal impairment. - Calcium channel blockers: observe for any unexpected reactions.